EMEA-001075-PIP04-15-M03

Key facts

Invented name
Evenity
Active substance
Romosozumab
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0255/2021
PIP number
EMEA-001075-PIP04-15-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of osteoporosis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
UCB Pharma S.A.

E-mail: UCBCares.UK@ucb.com
Tel. +44 1753777100

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings